SOLARA ACTIVE PHARMA SCIENCES
Back to All Ratios
|
SOLARA ACTIVE PHARMA SCIENCES Last 5 Year Core EBITDA Margin History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Core EBITDA Margin(%) | 13.19 | 14.99 | -6.85 | 9.27 | 6.31 |
What is the latest Core EBITDA Margin ratio of SOLARA ACTIVE PHARMA SCIENCES ?
| Year | Core EBITDA Margin |
|---|---|
| Mar2026 | 13.19 |
| Mar2025 | 14.99 |
| Mar2024 | -6.85 |
| Mar2023 | 9.27 |
| Mar2022 | 6.31 |
How is Core EBITDA Margin of SOLARA ACTIVE PHARMA SCIENCES Trending?
| Years | Core EBITDA Margin | % Change | |
|---|---|---|---|
| Mar2026 | 13.19 | -12.01 | |
| Mar2025 | 14.99 | Positive | |
| Mar2024 | -6.85 | Negative | |
| Mar2023 | 9.27 | 46.91 | |
| Mar2022 | 6.31 | - | |
Other Financial Ratios of SOLARA ACTIVE PHARMA SCIENCES
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Core EBITDA Margin ratio of peers of SOLARA ACTIVE PHARMA SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SOLARA ACTIVE PHARMA SCIENCES | ₹3,332.7 Cr | 9.5% | 37% | 2.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,316.0 Cr | -2.7% | -3.7% | 20.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,737.0 Cr | 3.7% | 15.7% | 51% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,594.0 Cr | -0.8% | 1% | 36.2% | Stock Analytics | |
| CIPLA | ₹110,515.0 Cr | -2.1% | -5.2% | -11.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,420.6 Cr | -0.8% | -0.5% | -9.3% | Stock Analytics | |
SOLARA ACTIVE PHARMA SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SOLARA ACTIVE PHARMA SCIENCES | 9.5% |
37% |
2.7% |
| SENSEX | -1.8% |
-3.7% |
-5.7% |
You may also like the below Video Courses